Kutatási jelek – Signal Engine

• AALL2331 Clinical Trial for Pediatric T‑Cell Blood Cancers — Acute lymphoblastic leukemia
• Thyroid Cancer — Thyroid cancer
• Undifferentiated and Dedifferentiated Melanoma of the Genitourinary Tract: A Case Series Demonstrating the Potential for Diagnostic Pitfalls — Melanoma
• Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success — Head and neck squamous cell carcinoma
• Five-Year Data Support Neoadjuvant THP in ERBB2-Positive Breast Cancer — Breast cancer
• New antibody drug stops aggressive prostate cancer from spreading — Prostate cancer
• Cervical Cancer: Background, Pathophysiology, Epidemiology — Cervical cancer
• SystImmune Announces Second Approval of Iza-bren in China for the Treatment of Recurrent or Metastatic Esophageal Squamous Cell Carcinoma — Nasopharyngeal carcinoma
• SB203580 (Adezmapimod) in Oncology and Cancer Research — Nasopharyngeal carcinoma
• Renal Cell Carcinoma Treatment & Management: Approach Considerations, Surgical Treatment, Molecular-Targeted Agents — Renal cell carcinoma
• KEYTRUDA (pembrolizumab) as Monotherapy Significantly Improved Progression‑Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy — Endometrial cancer
• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation-Positive Malignancies — NSCLC
• Relapsed/Refractory Multiple Myeloma: Rationale and Design of the MonumenTAL-3 Study — Multiple myeloma
• European Consortium for Waldenström's Macroglobulinemia — Waldenstrom macroglobulinemia
• Getting Involved in a Clinical Trial for GIST — Gastrointestinal stromal tumor
• A long‑standing mystery in the deadliest breast cancer just yielded 81 new treatment targets — Breast cancer
• Multi-Timepoint Risk Stratification in Rare Cancers: A Computational Framework Validated against Published Ewing Sarcoma Trial Data — Ewing sarcoma
• A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC — NSCLC
• Cervical cancer — Cervical cancer
• Genomic landscape of Ewing sarcoma: a pooled analysis of 538 cases and clinicopathological correlation — Ewing sarcoma